Citi Cuts Lithium Forecasts on Worsening Battery Demand Outlook
Citigroup Inc. cut its price targets for lithium for the next two years, citing concerns over a slowdown in battery demand growth, rising trade uncertainty and broader macroeconomic headwinds.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Bloomberg Markets; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersSouth Africa’s nationwide municipal elections on Wednesday hold few fears for investors, if market indicators are anything to go by. But shifts in broad support for the major political parties could provide a read on the…
South Africa’s nationwide municipal elections on Wednesday hold few fears for investors, if market indicators are anything to go by. But shifts in broad support…
Why it mattersGulf allies face mounting exposure to Iranian retaliation and regional conflict spillover, complicating U.S. Middle East strategy and energy security.
Gulf states fear another US-Israeli attack on Iran could unleash a more destructive war across the region, leaving them to pick up the pieces. Bloomberg's Micha…
Why it mattersEmerging-market currencies fell as investors weighed lingering Middle East tensions and awaited US economic data later this week.
Why it mattersAmgen's best chance at breaking into the high-stakes obesity drug market got its start in a basement at the University of Iceland Science Park in Reykjavík, in a freezer chilled to minus-13 degrees Fahrenheit. Bloomberg'…
Amgen's best chance at breaking into the high-stakes obesity drug market got its start in a basement at the University of Iceland Science Park in Reykjavík, in …